Pamyl (Pantoprazole Sodium Sesquihydrate)

Pantoprazole sodium sesquihydrate selectively blocks the H+/K+‑ATPase enzyme, commonly called the gastric proton pump, on the surface of stomach parietal cells. By inhibiting this final step of acid secretion, the drug raises gastric pH and reduces the amount of acid that reaches the oesophagus and duodenum, providing therapeutic benefit in acid‑related conditions.

The dosage of Pamyl is determined by the prescribing clinician based on the specific indication, severity of disease and patient characteristics. Healthcare professionals set the appropriate strength and frequency according to current clinical guidelines and the individual’s therapeutic needs.

Pantoprazole is classified as pregnancy category B in the EU, indicating that animal studies have not shown risk to the fetus and there are no adequate human studies. It should be used only if the potential benefit justifies any possible risk. Limited data are available for breastfeeding; a prescriber should weigh the advantages against potential exposure to the infant.

To request Pamyl, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements) and necessary import documentation.

Pamyl (pantoprazole) shares the same mechanism of action as other PPIs such as omeprazole, esomeprazole and lansoprazole, providing comparable acid suppression. Differences may lie in pharmacokinetic profiles, drug‑interaction potential and individual patient tolerance. Choice of PPI often depends on physician preference, drug‑interaction considerations and specific clinical scenarios.

Pamyl tablets should be stored at ambient temperature, below 25 °C, in their original packaging. Protect the product from moisture, excessive heat and direct sunlight to maintain stability and potency throughout its shelf life.

Pamyl is supplied as oral tablets that are taken by mouth, usually with water. It can be administered with or without food, but consistent timing each day helps maintain steady acid control. Patients should follow the prescribing clinician’s instructions regarding timing and any accompanying dietary recommendations.

Serious but rare risks include severe allergic reactions (anaphylaxis), Clostridioides difficile‑associated diarrhoea, low magnesium levels (hypomagnesemia) that may cause muscle cramps or cardiac arrhythmia, and potential bone fractures with long‑term use. Patients should report any unusual symptoms promptly to their healthcare provider.

Pamyl is contraindicated in patients with known hypersensitivity to pantoprazole or any other component of the formulation. Caution is also advised for individuals with severe liver impairment, those taking medications that require an acidic environment for absorption, and patients with a history of allergic reactions to other proton pump inhibitors.